Abstract
Management of head and neck cancer influences both physical and mental wellbeing. Measuring the health-related quality of life (HRQoL) is important, as various treatment modalities are associated with significant morbidity and mortality. In this prospective cohort study, we tested the feasibility of the generic 15D HRQoL instrument in 214 head and neck cancer patients managed with surgery, definitive (chemo)radiotherapy, or with combined modality treatment. HRQoL was assessed at baseline and three times after treatment onset during 1 year, and compared with that of general population standardized for age and sex. At baseline, the patients’ mean 15D score was significantly worse compared with general population. Overall HRQoL was at lowest at 3 months after treatment onset, it gradually improved towards 12 months but never reached baseline levels. The dimensions “vitality”, “distress”, “depression” and “sexual activity” showed marked deterioration at 3 months after the treatment onset, but improved gradually during 12 months. The 15D instrument seems useful for evaluation of HRQoL of head and neck cancer patients. Dimensions reflecting mental wellbeing improved gradually after 3 months, but they seldom reached baseline levels. The support for patients at the time of diagnosis, during treatment, and recovery is emphasized.
Similar content being viewed by others
References
Finnish Cancer Registry-Institute for Statistical and Epidemiological Cancer Research. http://www.cancer.fi/syoparekisteri/en/statistics/cancer-statistics/koko-maa/. Accessed May 5
The WHOQOL Group (1996) What quality of life? World Health Organization Quality of Life Assessment. World Health Forum 17:354–356
Rogers SN, Hogg ES, Cheung WK, Lai LK, Jassal P, Lowe D, Kanatas A (2014) ‘What will I be like’ after my diagnosis of head and neck cancer? Eur Arch Otorhinolaryngol. doi:10.1007/s00405-014-3189-x
Hassan SJ, Weymuller EA Jr (1993) Assessment of quality of life in head and neck cancer patients. Head Neck 15:485–496
Murphy BA, Ridner S, Wells N, Dietrich M (2007) Quality of life research in head and neck cancer: a review of the current state of the science. Crit Rev Oncol Hematol 62:251–267
Singer S, Araujo C, Arraras JI, Baumann I, Boehm A, Brokstad Herlofson B, Castro Silva J, Chie WC, Fisher S, Guntinas-Lichius O, Hammerlid E, Elisa Irarrazaval M, Jensen Hjermstad M, Jensen K, Kiyota N, Licitra L, Nicolatou-Galitis O, Pinto M, Santos M, Schmalz C, Sherman AC, Tomaszewska IM, Verdonck de Leeuw I, Yarom N, Zotti P, Hofmeister D, on behalf of the EORTC Quality of Life and the EORTC Head and Neck Cancer Groups (2014) Measuring quality of life in patients with head and neck cancer: update of the EORTC QLQ-H&N Module, Phase III, Head Neck. doi:10.1002/hed.23762
Stachler RJ, Schultz LR, Nerenz D, Yaremchuk KL (2014) PROMIS evaluation for head and neck cancer patients: a comprehensive quality-of-life outcomes assessment tool. Laryngoscope 124:1368–1376
Loimu V, Makitie AA, Back LJ, Sintonen H, Rasanen P, Roine R, Saarilahti K (2014) Health-related quality of life of head and neck cancer patients with successful oncological treatment. Eur Arch Otorhinolaryngol. doi:10.1007/s00405-014-3169-1
Sobin LH, Gospodarowicz M, Wittekind C (2009) UICC TNM classification of malignant tumours, 7th edn. Wiley, Hoboken, pp 54–57
Sintonen H, Maljanen T (1995) Explaining the utilisation of dental care. Experiences from the Finnish dental market. Health Econ 4:453–466
Stavem K (1999) Reliability, validity and responsiveness of two multiattribute utility measures in patients with chronic obstructive pulmonary disease. Qual Life Res 8:45–54
Sintonen H (2001) The 15D instrument of health-related quality of life: properties and applications. Ann Med 33:328–336
Hawthorne G, Richardson J, Day NA (2001) A comparison of the assessment of quality of life (AQoL) with four other generic utility instruments. Ann Med 33:358–370
Moock J, Kohlmann T (2008) Comparing preference-based quality-of-life measures: results from rehabilitation patients with musculoskeletal, cardiovascular, or psychosomatic disorders. Qual Life Res 17:485–495
Alanne S, Roine RP, Rasanen P, Vainiola T, Sintonen H (2015) Estimating the minimum important change in the 15D scores. Qual Life Res 24:599–606
Saarni SI, Harkanen T, Sintonen H, Suvisaari J, Koskinen S, Aromaa A, Lonnqvist J (2006) The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D. Qual Life Res 15:1403–1414
Ilmarinen T, Nissila H, Rihkanen H, Roine RP, Pietarinen-Runtti P, Pitkaranta A, Aaltonen LM (2011) Clinical features, health-related quality of life, and adult voice in juvenile-onset recurrent respiratory papillomatosis. Laryngoscope 121:846–851
Hytonen ML, Lilja M, Makitie AA, Sintonen H, Roine RP (2012) Does septoplasty enhance the quality of life in patients? Eur Arch Otorhinolaryngol 269:2497–2503
Wiksten J, Blomgren K, Roine RP, Sintonen H, Pitkaranta A (2013) Effect of tonsillectomy on health-related quality of life and costs. Acta Otolaryngol 133:499–503
Farkkila N, Sintonen H, Saarto T, Jarvinen H, Hanninen J, Taari K, Roine RP (2013) Health-related quality of life in colorectal cancer. Colorectal Dis 15:e215–e222
Torvinen S, Farkkila N, Sintonen H, Saarto T, Roine RP, Taari K (2013) Health-related quality of life in prostate cancer. Acta Oncol 52:1094–1101
Durmus K, Patwa HS, Gokozan HN, Kucur C, Teknos TN, Agrawal A, Old MO, Ozer E (2014) Functional and quality-of-life outcomes of transoral robotic surgery for carcinoma of unknown primary. Laryngoscope 124:2089–2095
Chen AM, Daly ME, Farwell DG, Vazquez E, Courquin J, Lau DH, Purdy JA (2014) Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy. JAMA Otolaryngol Head Neck Surg 140:129–133
Terrell JE, Ronis DL, Fowler KE, Bradford CR, Chepeha DB, Prince ME, Teknos TN, Wolf GT, Duffy SA (2004) Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 130:401–408
Tulunay-Ugur OE, McClinton C, Young Z, Penagaricano JA, Maddox AM, Vural E (2013) Functional outcomes of chemoradiation in patients with head and neck cancer. Otolaryngol Head Neck Surg 148:64–68
Bhayani MK, Hutcheson KA, Barringer DA, Lisec A, Alvarez CP, Roberts DB, Lai SY, Lewin JS (2013) Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence. Head Neck 35:1634–1640
Bhayani MK, Hutcheson KA, Barringer DA, Roberts DB, Lewin JS, Lai SY (2013) Gastrostomy tube placement in patients with hypopharyngeal cancer treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence. Head Neck 35:1641–1646
Silander E, Nyman J, Bove M, Johansson L, Larsson S, Hammerlid E (2012) Impact of prophylactic percutaneous endoscopic gastrostomy on malnutrition and quality of life in patients with head and neck cancer: a randomized study. Head Neck 34:1–9
Starmer HM, Yang W, Raval R, Gourin CG, Richardson M, Kumar R, Jones B, McNutt T, Cheng Z, Quon H (2014) Effect of gabapentin on swallowing during and after chemoradiation for oropharyngeal squamous cell cancer. Dysphagia 29:396–402
Kuntz AL, Weymuller EA Jr (1999) Impact of neck dissection on quality of life. Laryngoscope 109:1334–1338
Chepeha DB, Taylor RJ, Chepeha JC, Teknos TN, Bradford CR, Sharma PK, Terrell JE, Wolf GT (2002) Functional assessment using Constant’s Shoulder Scale after modified radical and selective neck dissection. Head Neck 24:432–436
Terrell JE, Welsh DE, Bradford CR, Chepeha DB, Esclamado RM, Hogikyan ND, Wolf GT (2000) Pain, quality of life, and spinal accessory nerve status after neck dissection. Laryngoscope 110:620–626
Maxwell JH, Mehta V, Wang H, Cunningham D, Duvvuri U, Kim S, Johnson JT, Ferris RL (2014) Quality of life in head and neck cancer patients: impact of HPV and primary treatment modality. Laryngoscope 124:1592–1597
Mahmood R, Butterworth C, Lowe D, Rogers SN (2014) Characteristics and referral of head and neck cancer patients who report chewing and dental issues on the Patient Concerns Inventory. Br Dent J 216:E25
Hoffman KE, Pugh SL, James JL, Scarantino C, Movsas B, Valicenti RK, Fortin A, Pollock J, Kim H, Brachman DG, Berk LB, Bruner DW, Kachnic LA (2014) The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial. Qual Life Res 23:1841–1858
Acknowledgments
This study has been supported by grants from the Helsinki University Hospital Research Funds.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors claim no conflict of interest.
Rights and permissions
About this article
Cite this article
Aro, K., Bäck, L., Loimu, V. et al. Trends in the 15D health-related quality of life over the first year following diagnosis of head and neck cancer. Eur Arch Otorhinolaryngol 273, 2141–2150 (2016). https://doi.org/10.1007/s00405-015-3732-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-015-3732-4